Significant delay in the progression to dialysis/ESIRD for AA amyloidosis patients treated with eprodisate (NC-503): 3 years of follow-up

Author
Merlini, G.
Lachmann, H.
Puechal, V
Dember, L.
Hauck, W.
Hatemi, G.
Ozdogan, H.
Hazenberg, B.
Gul, A.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/162348
Collections